ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 22 filers reported holding ARGOS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $354,000 | -30.2% | 153,233 | +68.9% | 0.05% | -40.2% |
Q3 2015 | $507,000 | -2.9% | 90,733 | +19.2% | 0.09% | -20.9% |
Q2 2015 | $522,000 | -27.0% | 76,110 | -5.1% | 0.11% | +11.1% |
Q1 2015 | $715,000 | -6.4% | 80,230 | -12.7% | 0.10% | +5.3% |
Q4 2014 | $764,000 | -17.8% | 91,915 | -0.5% | 0.09% | -8.7% |
Q3 2014 | $929,000 | +90.4% | 92,415 | +22.5% | 0.10% | +80.7% |
Q2 2014 | $488,000 | -26.2% | 75,415 | +1.3% | 0.06% | -32.1% |
Q1 2014 | $661,000 | – | 74,415 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pharmstandard International S.A. | 13,242,279 | $4,808,000 | 16.67% |
Pharmstandard International S.A. | 5,120,604 | $1,859,000 | 6.44% |
SANDERS MORRIS HARRIS LLC | 141,212 | $52,000 | 0.02% |
ELEMENT CAPITAL MANAGEMENT LLC | 82,808 | $30,000 | 0.01% |
WEDBUSH SECURITIES INC | 89,500 | $32,000 | 0.00% |
Alyeska Investment Group, L.P. | 200,000 | $73,000 | 0.00% |
LMR Partners LLP | 45,017 | $16,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 129,046 | $46,000 | 0.00% |
STATE STREET CORP | 11,900 | $4,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 193,294 | $70,000 | 0.00% |